2022 annual financial data
Regencell Bioscience 2022 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -7,617,770 USD and net income was -7,422,728 USD.
Operating cash flow was -5,267,055 USD.
Get free Regencell Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -7,617,770 USD
- Net income
- -7,422,728 USD
- Operating cash flow
- -5,267,055 USD